Edition:
United States

Boule Diagnostics AB (BOUL.ST)

BOUL.ST on Stockholm Stock Exchange

261.00SEK
21 Sep 2017
Change (% chg)

1.00kr (+0.38%)
Prev Close
260.00kr
Open
256.50kr
Day's High
263.00kr
Day's Low
256.50kr
Volume
2,947
Avg. Vol
11,222
52-wk High
378.00kr
52-wk Low
133.25kr

Chart for

About

Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that... (more)

Overall

Beta: 1.12
Market Cap(Mil.): kr1,236.34
Shares Outstanding(Mil.): 4.76
Dividend: 1.40
Yield (%): 0.54

Financials

  Industry Sector
P/E (TTM): -- 178.51 16.33
EPS (TTM): -- -- --
ROI: -- 9.49 14.66
ROE: -- 14.73 13.99

BRIEF-Boule Diagnostics appoints ‍christina Rubenhag new CFO

* ‍CHRISTINA RUBENHAG NEW CFO FROM OCT.9 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 20 2017

BRIEF-Boule Diagnostics Q2 net result swings to loss SEK 1.1 mln

* Q2 NET SALES SEK ‍104.3​ MILLION VERSUS SEK 102.0 MILLION YEAR AGO

Aug 25 2017

BRIEF-Boule Diagnostics closes factory in China

* BOULE DIAGNOSTICS OPTIMIZES MANUFACTURING STRUCTURE - CLOSES FACTORY IN CHINA

May 16 2017

BRIEF-Boule Diagnostics Q1 operating profit rises to SEK 12.0 mln

* Q1 NET SALES SEK 106.6 MILLION VERSUS SEK 84.4 MILLION YEAR AGO

May 11 2017

Earnings vs. Estimates